BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11220659)

  • 1. Intermediate biomarkers for chemoprevention of prostate cancer.
    van der Kwast TH
    IARC Sci Publ; 2001; 154():199-205. PubMed ID: 11220659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic intraepithelial neoplasia (PIN) and other prostatic lesions as risk factors and surrogate endpoints for cancer chemoprevention trials.
    Bostwick DG; Aquilina JW
    J Cell Biochem Suppl; 1996; 25():156-64. PubMed ID: 9027613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade prostatic intraepithelial neoplasia in needle biopsy as risk factor for detection of adenocarcinoma: current level of risk in screening population.
    Gokden N; Roehl KA; Catalona WJ; Humphrey PA
    Urology; 2005 Mar; 65(3):538-42. PubMed ID: 15780372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?
    Naya Y; Ayala AG; Tamboli P; Babaian RJ
    Urology; 2004 Mar; 63(3):503-8. PubMed ID: 15028446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic intraepithelial neoplasia and prostate cancer.
    Montironi R; Santinelli A; Mazzucchelli R
    Panminerva Med; 2002 Sep; 44(3):213-20. PubMed ID: 12094135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy.
    Kronz JD; Shaikh AA; Epstein JI
    Hum Pathol; 2001 Apr; 32(4):389-95. PubMed ID: 11331955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic intraepithelial neoplasia is a risk factor for cancer.
    Bostwick DG
    Semin Urol Oncol; 1999 Nov; 17(4):187-98. PubMed ID: 10632120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic regulators in prostatic intraepithelial neoplasia (PIN): value in prostate cancer detection and prevention.
    Zeng L; Kyprianou N
    Prostate Cancer Prostatic Dis; 2005; 8(1):7-13. PubMed ID: 15477876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of prostate-specific antigen in the chemoprevention of prostate cancer.
    Crawford ED; DeAntoni EP; Ross CA
    J Cell Biochem Suppl; 1996; 25():149-55. PubMed ID: 9027612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic intraepithelial neoplasia: significance and management.
    Lipski BA; Garcia RL; Brawer MK
    Semin Urol Oncol; 1996 Aug; 14(3):149-55. PubMed ID: 8865477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of prostate-specific antigen velocity to follow up patients with isolated high-grade prostatic intraepithelial neoplasia on prostate biopsy.
    Loeb S; Roehl KA; Yu X; Han M; Catalona WJ
    Urology; 2007 Jan; 69(1):108-12. PubMed ID: 17270629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy.
    Morote J; Fernández S; Alaña L; Iglesias C; Planas J; Reventós J; Ramón Y Cajal S; Paciucci R; de Torres IM
    Clin Cancer Res; 2008 May; 14(9):2617-22. PubMed ID: 18451224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
    Goeman L; Joniau S; Ponette D; Van der Aa F; Roskams T; Oyen R; Van Poppel H
    Prostate Cancer Prostatic Dis; 2003; 6(4):305-10. PubMed ID: 14663472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy.
    Borboroglu PG; Sur RL; Roberts JL; Amling CL
    J Urol; 2001 Sep; 166(3):866-70. PubMed ID: 11490235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer.
    Alcaraz A; Barranco MA; Corral JM; Ribal MJ; Carrió A; Mallofré C; Llopis J; Cetina A; Alvarez-Vijande R
    Prostate; 2001 Apr; 47(1):29-35. PubMed ID: 11304727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of high-grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens.
    Wills ML; Hamper UM; Partin AW; Epstein JI
    Urology; 1997 Mar; 49(3):367-73. PubMed ID: 9123700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy.
    Park S; Shinohara K; Grossfeld GD; Carroll PR
    J Urol; 2001 May; 165(5):1409-14. PubMed ID: 11342887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen deprivation therapy for precancerous lesions of the prostate.
    Hull D; Bostwick DG
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):285-91. PubMed ID: 18471786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do all patients with high-grade prostatic intraepithelial neoplasia on initial prostatic biopsy eventually progress to clinical prostate cancer?
    Izawa JI; Lega I; Downey D; Chin JL; Luke PP
    BJU Int; 2005 Aug; 96(3):320-3. PubMed ID: 16042722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of serum-free and total prostate-specific antigen due to prostatic intraepithelial neoplasia.
    Minardi D; Galosi AB; Dell'Atti L; Hanitzsch H; Mario P; Muzzonigro G
    Scand J Urol Nephrol; 2002; 36(5):323-9. PubMed ID: 12487735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.